Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F98F6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,214
Award facts
- Contract value 100% obligated
- $16,213.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $16,213.59 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 30, 2026, for the supply of Dupixent 300 mg/2 mL pen injections. The contract, with an ultimate completion date of February 2, 2026, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems. This delivery order is issued under the company's parent organization, Cencora, Inc. (doing business as AmerisourceBergen), which holds a significant Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031.
Dupixent is a biologic medication primarily used to treat conditions such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. This delivery order represents a routine pharmaceutical procurement to support the Defense Health Agency's medical supply chain and military treatment facilities. AmerisourceBergen's extensive portfolio of federal pharmaceutical contracts demonstrates its established capability to meet competitive procurement requirements across multiple therapeutic domains, including specialty biologics, brand-name medications, and generic drugs that support the Department of Defense healthcare mission globally.
Quick answers
Who was awarded contract SPE2DR26F98F6?
SPE2DR26F98F6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F98F6 worth?
The government has obligated $16,214 on SPE2DR26F98F6.
Is contract SPE2DR26F98F6 an order under another contract?
Yes. SPE2DR26F98F6 is a delivery order under SPE2DR25D3505, an indefinite delivery contract.
Was contract SPE2DR26F98F6 competed?
The extent of competition for SPE2DR26F98F6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award